Cargando…
A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer
PURPOSE: Insufficient sensitivity and specificity prevent the use of most existing biomarkers for early detection of breast cancer. Recently, it was reported that serum microRNAs (miRNAs) may be potential biomarkers in many cancer diseases. In this study, we investigated whether serum levels of 5 mi...
Autores principales: | Han, Ji-Guang, Jiang, Yong-Dong, Zhang, Chun-Hui, Yang, Yan-Mei, Pang, Da, Song, Yan-Ni, Zhang, Guo-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309178/ https://www.ncbi.nlm.nih.gov/pubmed/28203552 http://dx.doi.org/10.4174/astr.2017.92.2.55 |
Ejemplares similares
-
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019) -
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023) -
miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014) -
MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
por: Park, Sunyoung, et al.
Publicado: (2017) -
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)